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 SUMMARY STATEMENT  
Acute otitis media is an important disease in children. We describe a new infection model for 
translational research that uses the Mecom mouse mutant intranasally inoculated with non-
typeable Haemophilus influenzae. 
 
ABSTRACT 
Acute otitis media, inflammation of the middle ear, is the most common bacterial infection in 
children and as a consequence is the most common reason for antimicrobial prescription to 
this age group. There is currently no effective vaccine for the principal pathogen involved, 
non-typeable Haemophilus influenzae (NTHi).  
The most frequently used and widely accepted experimental animal model of middle ear 
infection is in chinchillas, but mice and gerbils have also been used. We have established a 
robust model of middle ear infection by NTHi in the Junbo mouse, a mutant mouse line that 
spontaneously develops chronic middle ear inflammation under specific pathogen free 
conditions. The heterozygote Junbo mouse (Jbo/+) bears a mutation in a gene (Evi1, also 
known as Mecom) that plays a role in host innate immune regulation; pre-existing middle ear 
inflammation promotes NTHi middle ear infection. A single intranasal inoculation with 
NTHi produces high rates (up to 90%) of middle ear infection and bacterial titers (104 to 105 
CFU/l) in bulla fluids. Bacteria are cleared from the majority of middle ears between day 21 
and 35 post-inoculation but remain in approximately 20% of middle ears at least up to day 56 
post-infection. The expression of TLR-dependent response cytokine genes is elevated in the 
middle ear of the Jbo/+ mouse following NTHi infection.  The translational potential of the 
Junbo model for studying antimicrobial intervention regimens was shown using a 3-day 
course of Azithromycin to clear NTHi infection, and its potential use in vaccine development 
studies by demonstrating protection in mice immunized with killed homologous, but not 
heterologous, NTHi bacteria.  
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 INTRODUCTION 
Acute otitis media (AOM) is primarily caused by the bacterial commensal pathogens non-
typeable Haemophilus influenzae (NTHi), Streptococcus pneumoniae (pneumococcus), and 
Moraxella catarrhalis. AOM is the most common bacterial infection in children and as a 
consequence is the commonest reason for antibiotic prescription during childhood accounting 
for 24.5 million physician office visits per year in the US (Bakaletz, 2009). The global health 
burden of AOM is significant; of an estimated 709 million cases per year, 31 million children 
go on to develop chronic suppurative OM (with otorrhea i.e. perforation of the tympanic 
membrane and drainage of pus) and an estimated 21,000 deaths occur each year from 
complications such as meningitis (Monasta et al., 2011). 
The chinchilla otitis media model was first developed to study pneumococcus 
infection (Giebink et al. 1976). It has subsequently become the most frequently used model 
for NTHi infection studies, vaccine development, and is considered to be a robust, 
reproducible model for polymicrobial infections (Bakaletz, 2009). Following direct 
inoculation of the chinchilla bulla, NTHi can form a biofilm that promotes bacterial survival 
against the host response and treatment (Jurcisek and Bakaletz, 2007;  Brockson et al., 2014). 
In addition to the chinchilla, there is increasing use of inbred strains of mice and mouse 
mutants in OM research (Ryan et al., 2006; Sabirov and Metzger, 2008, Hernandez et al., 
2015). In chinchillas and mice, direct injection of bacteria into the middle ear (ME) bulla is 
efficient and allows the dose to be controlled, but intranasal (IN) inoculation that mimics 
natural ascending Eustachian tube (ET) infection produces only sporadic ME infection in 
mice (Ryan et al., 2006) and no ME infection in chinchillas (Bakaletz, 2009). However, IN 
inoculation of the chinchilla produces sustained infection of the ME when it is used in 
conjunction with barotrauma (lowering pressure in the ME) (Giebink et al., 1979) or 
following virus infection (Giebink, 1981). In mice, IN inoculation results in colonisation of 
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 the nasopharynx (NP) and subsequent ME infection is enhanced by repeated IN inoculation 
(Sabirov and Metzger, 2006), when IN inoculation is used in conjunction with virus infection 
(McCullers et al., 2007; Short et al., 2013) or barotrauma (by raising environmental air 
pressure) (Stol et al., 2009). 
Mice with mutations in TGF- signaling pathway genes that modulate pro-
inflammatory responses or mutations that lead to ET malformation are predisposed to 
develop OM spontaneously without the need for bacterial challenge and a number of these 
genes are also implicated in modulating susceptibility to human OM (review by Rye et al., 
2010).  
In this study we focus on NTHi induced ME infection in the Junbo mouse, a mutant 
mouse line that spontaneously develops chronic ME inflammation under specific pathogen 
free (SPF) conditions. The heterozygote Junbo mouse (Jbo/+) bears an Asn763Ile mutation 
in the gene encoding the transcription factor Evi1, also known as Mecom (Parkinson et al., 
2006). One mechanism that may underlie the predisposition to OM in Jbo/+ mice is that Evi1 
is a negative regulator of NFkB and the loss of function Evi1 Junbo mutation exacerbates 
NTHi induced inflammation in the lung (Xu et al., 2011).  
We hypothesized that the ME inflammation in Jbo/+ mice could provide a niche in 
which, after IN challenge, bacteria would establish infection following contiguous spread 
along the ET.  As a proof of this concept and its utility as a validated animal model of otitis 
media, we used the human commensal pathogen NTHi to establish ME infection. We have 
characterized the dynamics and host responses to NP colonization and OM, using multiple, 
genetically distinct NTHi strains. Our data demonstrate the utility of the Jbo/+ model for 
testing immunization and antibiotics strategies aimed at the prevention or treatment of NTHi 
infection of the ME.  
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 RESULTS 
NTHi inoculated intranasally infect the ME of Jbo/+ mice for at least 56 days 
We have successfully established a robust model of ME infection using a single IN 
inoculation with the commensal pathogen NTHi in the Junbo mouse. Seven well studied and 
unrelated NTHi isolates from human OM and one from lower respiratory tract disease (strain 
2019) were inoculated IN (108 CFU) into 8-week-old SPF Jbo/+ mice then sampled after 
culling on day 7 post-infection. For seven of the NTHi isolates, high bacterial titers of 104–
105 CFU/l were obtained from 30-90% of infected ME bullae (Fig. 1A and 1C). Infection 
with NTHi 176 was unsuccessful. Strains NTHi 162 and 375 were chosen as the principal test 
strains for subsequent experiments. 
The ME infection rates (Fig. 1B) and titers (Fig. 1D) were not significantly different 
when inocula ranging from 104 to 108 CFU NTHi 162 were used. Following an IN challenge 
of 103 CFU, a significant increase in ME NTHi load 7 days post-infection was detected (104.7 
CFU/l,104.2 - 105.3 95% CI, n=7, P=0.000185, 1 sample t-test), however the ME infection 
rate was reduced with this low inoculum size (24% vs 75% for 103 and 106 CFU 162sr 
inoculation groups (n=15) respectively, P=0.000178). 
The potential for rapid transfer of bacteria from the NP to the ME was demonstrated 
following IN inoculation with 108 CFU of strain NTHi 162lux. Within minutes a 
bioluminescent signal was distributed along the full length of the NP (Fig. 2A), NTHi were 
adjacent with the ET opening even though the inoculation volume (10 l) is small relative to 
that of the nasal cavity (30 l) (Maronpot et al., 1999). Subsequent spread and dilution of the 
inoculum resulted in insufficient signal to permit direct monitoring of bacterial movement 
from the NP. We therefore administered IN 108 FITC labeled 1 m microspheres as a marker 
for ET ascension. Five minutes after administration the numbers of microspheres in 
histological sections of the ET were not significantly different between 9-week-old Jbo/+ 
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 mice (median 28 per mm, 95% CI, 12-77) and wild-type littermate mice (median 29 per mm, 
95% CI, 8-39; P=0.6569).  
We examined ascending ET infection in 8-week-old Jbo/+ mice by sampling bulla 
fluids and detected NTHi at 1 hr, 3 hr, 6 hr and 24 hr post IN inoculation with 106 CFU NTHi 
strain 162sr. With a 10 CFU/l detection limit for NTHi, ME bulla fluid infection rates were 
high (≥70%) from 1 hr onwards (Fig. 2B). ME NTHi titers were 103.2-103.7 CFU/l at 1-6 hr 
and increased significantly to 104.7 CFU/l (104.2 -105.2 95% CI) by 24 hr post-inoculation 
(Fig. 2D). Over a 56 day time course ME infection rates were consistently high (≥60%) 4-14 
days post-inoculation then declined to ~20% and were maintained at this rate over the period 
from day 35-56 (Fig. 2C). ME titers peaked at day 10 and remained at ~104 -105 CFU/l up to 
day 56 (Fig. 2E), the last period sampled.   
There was a strong positive association (P=2.62E-16) between NTHi infection in the 
ME and NP (Table S1) and ME/NP co-infection declines with time (Fig. S1). The recovery of 
NTHi by NP washing is only semi-quantitative and the counts were generally low, 101.1 CFU 
(100.9 -101.1 95% CI, n=86 in 50 l sample of 200 l wash volume).  
The histology of the NTHi infected middle ear was examined in 12-week-old Jbo/+ 
mice at day 7 post IN inoculation. To maintain the anatomical integrity of the bulla contents 
the tympanic membrane (TM) was not opened. A necrotic caseous core of neutrophils is 
surrounded by viable and apoptotic neutrophils (cleaved caspase 3 positive) and an outer, 
variably thick, band of foamy macrophages (F 4/80 positive) (Fig. 3A-E). There were 
variable amounts of amorphous extracellular chromatin within the caseous areas (Fig. 3F). 
The larger accumulations were histone 3 negative, but smaller granular aggregates were 
histone 3 positive (Fig. 3G). Neutrophil leukocytes were present in the ET lumen and ET 
mucosa at its junction with the NP and in the ET lumen where it opens into the ME (Fig. 3H, 
Fig. 3I). The NP mucosa adjacent to the ET opening was not inflamed. Taken together this 
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 data is consistent with an interpretation that the relatively large NTHi populations in the ME 
act as a reservoir for re-infection through contiguous descending spread from the ME to the 
NP along with efflux of exudate.  The overall histology of chronic OM in 12-week-old Jbo/+ 
mice was not significantly different between NTHi challenged and non-challenged mice. 
60% (median, 95% CI, 50-75) and 67% (33-81; P=0.5339) of the bulla was occupied by 
neutrophils and foamy macrophages and the thickness of middle ear mucosa was 100 µm 
(84-104) and 111 µm (79-150; P=0.086) in NTHi challenged and non-challenged Jbo/+ mice 
respectively. 
Gram staining failed to reveal Gram-negative coccobacilli in foamy macrophages, and 
the presence of abundant karyorrhectic nuclear debris in the necrotic core confounded 
unequivocal demonstration of Gram-negative bacteria in the center of the mass. To localize 
NTHi bacteria in the bulla we used in situ hybridization targeting the 16S rRNA of NTHi and 
this gave strong signals from the bulla exudate but not elsewhere in head tissues from Jbo/+ 
mice challenged with NTHi 162. NTHi hybridization signals comprised punctate or larger 
aggregates and were scattered throughout bulla exudate but were less frequent in the caseous 
core (Fig. 2 J, K). Evidence consistent with the presence of significant or mature biofilm was 
not found. In contrast, NTHi hybridization signals were absent in non-challenged Jbo/+ 
control mice (Fig. 2 L, M).    
 
Bulla fluids are critical for NTHi infection in different mouse backgrounds  
97.2% (71/73) of NTHi inoculated 8-week-old wild-type mice had healthy ears (a clear TM 
with no detectable intra-bulla fluid) and PBS washes were NTHi culture negative. Only two 
(of 73) NTHi inoculated wild-type mice had OM; both had unilateral disease and the bulla 
fluids were NTHi culture positive, indicating that NTHi infection of the wild-type mouse ME 
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 was indeed a rare event. A proportion of NTHi inoculated Jbo/+ mice have unilateral or no 
OM (see below). Only 1.4% (3/206) of PBS washes from these healthy Jbo/+ ears gave 
NTHi positive cultures.  
NTHi infection in the Jbo/+ mouse did not alter the frequency of OM. The incidence 
of ME bulla fluids, judged by TM opacity, in n=81 NTHi challenged Jbo/+ mice aged 8 
weeks and inoculated with108 CFU NTHi (pooled data from experiments with 7 NTHi 
strains) and sampled 7 days later was not significantly different to previously published data 
on non-challenged 8 week Jbo/+ mice (n=54) (Cheeseman et al., 2011); bilateral OM 85.1% 
vs 77.8%, unilateral OM 13.6% vs 13.0%, no macroscopic ME disease 1.2% vs 9.3%, each 
respectively (P=0.10 2x3 Fisher exact test). 
8-week-old Jbo/+ mice congenic on a BALB/c background also had a spontaneous 
OM phenotype and NTHi ME infection rates and titers were similar to those seen in Jbo/+ 
mice congenic on the standard C3H/HeH background used in this study. For other mutant 
mouse lines with a spontaneous OM phenotype when infected by NTHi, 8-14 week old Tgif 
(Tgif -/-) (Tateossian et al., 2013) has lower ME titers and 7-8 week old Jeff (Jf/+) (Hardisty-
Hughes et al., 2006) have the lowest ME titers and infection rates compared to Jbo/+ (Fig. 
S2).   Together these results indicate that pre-existing inflammation and ME bulla fluid is a 
necessary requirement for NTHi colonization/infection. IN inoculation with NTHi does not 
efficiently induce OM in the healthy fluid-free ME of either wild-type or Jbo/+ mice nor 
does it increase the incidence of bulla fluids in Jbo/+ mice. Furthermore, mice with different 
OM–related mutations behave differently with respect to NTHi infection and do not simply 
facilitate a non-specific access of bacteria to infect the ME. 
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 The role of indigenous mouse ME flora 
The natural flora of the Jbo/+ mouse has the potential to influence the outcome of NTHi 
infection experiments. A requirement for indigenous NP flora in spontaneous OM was 
investigated by generating germ free (GF) Jbo/+ mice. The incidence of OM in the GF and 
specific pathogen free (SPF) Jbo/+ mice was the same but its onset was slightly later, at 5 
weeks rather than 4 weeks, under GF conditions. The histological features of OM in GF 
Jbo/+ mice were inflammatory thickening of the bulla mucosa and accumulation of 
neutrophil leukocytes and foamy macrophages in the bulla fluid. There were occasional 
plant-based foreign bodies from bedding or food in the bulla fluid (Fig. 4). This 
histopathology is indistinguishable from the previously described pattern in SPF Jbo/+ mice  
(Parkinson et al., 2006; Cheeseman et al., 2011). Thus, normal flora microbial is not an 
absolute requirement for the Jbo/+ mouse to develop OM. 
SPF Junbo mice were utilized in our standard NTHi infection experiments. Routine 
microbiological surveillance of the NP in sentinel mice from our SPF animal facility revealed 
the mice were free of all FELASA listed mouse pathogens and the presence of the following 
NP commensals (NP positive culture as a percentage of n=1150 mice sampled): Enterobacter 
spp 2.8%, E. coli 2.3%, Lactobacillus spp 0.7%, Proteus spp 22.7%, Staphylococcus aureus 
62.9%, Staphylococcus spp (not Staph. aureus) 56.2%, alpha-hemolytic Streptococcus spp 
94.3%, and Streptococcus spp (not beta-hemolytic or S. pneumoniae) 37.0%. The effect of 
ME commensal bacteria on NTHi titers in ME bulla fluids was investigated in 12 week old 
Jbo/+ mice inoculated with 106 CFU NTHi 162sr by comparing growth on selective 
(antibiotic) and non-selective plates. NTHi titers were very similar when ME bulla fluids had 
pure NTHi cultures (104.5 CFU/l; 104.3-104.8 95% CI, n=59) or mixed cultures with NTHi 
and Proteus or other commensals (104.5 CFU/l; 104.3 -104.7, n=74). 
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 Population dynamics of NTHi infection  
When two NTHi strains able to be monitored independently, 162lux and 375, were co-
inoculated into 8-10 week old Jbo/+ mice, 83% of ME gave rise to a mixed culture of both 
strains at day 1 but 71% of ME gave a monoculture of one or the other, but not both, strains 
at day 7. In this period ME infection rates remained high, ME titers of each strain were 
comparable in co-infections, but NTHi 162lux monocultures predominated by day 7 (Fig. 5). 
Of interest, in at least one mouse the right and left ME were infected by monoculture of the 
alternative NTHi strains indicating that each middle ear can operate as a separate 
compartment for growth and selection within the same animal.   
Jbo/+ mouse produces an innate immune response in the ME to NTHi infection  
The host innate immune response was assessed in the ME of 8-10 week old Jbo/+ mice 
following NTHi infection using 8-10 week old Jbo/+ GF mice as a sterile inflammatory 
baseline control. We chose to study expression of TLR response cytokine genes  that are 
likely to be activated by NTHi ligands binding to TLR-receptors (e.g. TLR2, TLR4, TLR9) 
that are expressed by macrophages, monocytes and neutrophils (http://www.immgen.org) and 
are relevant to OM and AOM (Juhn et al., 2008; Kaur et al., 2015). We used bulla samples 
collected from mice at 1, 4, 7 and 14 days post-inoculation with 106 CFU NTHi 375 when 
NTHi infection rates were ≥70% (Fig. 6A) and bacterial titers in the range 104.4 -104.7 CFU/l 
(Fig. 6B). Gene expression patterns varied; IL-17a, Tnfa, Ccl3 and Ccl4 showed the highest 
relative upregulation (4 to 64 fold) throughout this time course relative to GF baseline 
controls (Fig. 5C); IL-1b, IL-12a, declined slightly at the day 3 time point but were otherwise 
moderately elevated (≥2 fold). Vegf, a marker for hypoxia in the inflammatory environment, 
did not change (≤2 fold) (Fig. 6D), Ccl5 and IL-6 were elevated at day 1 but declined to 
baseline levels by day 14 (Fig. 6E).  
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 The combined data from NTHi infections indicate that the Jbo/+ mouse is an 
important new infection model that can facilitate study of NTHi pathogenesis and OM 
disease. ME infection of mice is achieved efficiently by a single IN inoculation with NTHi, 
producing high rates of ME infection and bacterial titers in bulla fluids that are sustained in a 
proportion of ME up to 56 days post-inoculation. NTHi co-exists with indigenous bacteria in 
SPF mice but still induces a host innate response following infection.  Having established a 
robust NTHi infection model for the study of OM pathogenesis we then explored its potential 
translational utility in challenge (vaccines) studies and treatment (antimicrobials). 
An adaptive immune response in the Jbo/+ mouse is protective against NTHi challenge 
with a homologous NTHi strain  
Following the advent of multivalent pneumococcal vaccines, NTHi is now the leading cause 
of OM (Benninger, 2008) but currently there are no effective vaccines against this bacterium. 
An initial assessment of the Jbo/+ mouse as a model for vaccine studies was made by 
immunizing 5-week-old Jbo/+ mice subcutaneously with killed NTHi 162. At 12 weeks, 
mice were inoculated IN with live NTHi 162sr, the homologous strain. Terminal assessment 
at day 7 post-inoculation revealed significantly reduced ME infection rates compared to PBS 
immunized control animals (15% versus 81%, P=9.15E-12) (Fig. 7 A). In mice that were 
NTHi culture positive, ME infection was unilateral and titers were significantly lower to 
those in PBS-immunized controls (P=1.41E-03) (Fig. 7 B). For mice that were immunized 
with killed heterologous NTHi strains 176 or 375, then inoculated IN with live strain 162sr, 
there was no significant protection indicated by ME infection rates, however, bacterial titers 
were ~1 log10 lower compared to PBS-immunized controls (P=0.00015 and P=0.0011 for 176 
and 375 respectively) (Fig. 7 A and 7 B). Thus, the antibody response against NTHi in the 
Jbo/+ mouse can provide protection and can discriminate between homologous and 
heterologous NTHi challenge. 
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 Azithromycin treatment eliminates NTHi ME infection  
Antibiotic resistance in the clinical setting is on the increase for commensal pathogens 
(Benninger, 2008); this has the potential to impact on treatment regimens for disease caused 
by NTHi, including OM. To make a preliminary assessment of the Jbo/+ mouse model for 
testing new antimicrobials or antibiotic delivery strategies we treated 8-week-old Jbo/+ mice 
with a 3-day course of Azithromycin (100 mg/kg) starting at day 4 post-inoculation with 
NTHi 162. Compared to untreated mice where ME infection was detected on day 1 post-
inoculation and was maintained in ≥80% of ME at titers of 104-105 CFU/l from day 4-14 
(Fig. 8 A and 8 C), NTHi had been eliminated from all ME bulla fluids of azithromycin 
treated mice (Fig. 8 B and 8 D). This data provides initial evidence of the potential for the 
Jbo/+ mouse to be used for efficient screening of antimicrobial agents or treatment regimens 
for OM.  
IN challenge with the pneumococcus.  
To investigate whether ME infection could be achieved with the other major human 
otopathogen, 8-week-old Jbo/+ mice were inoculated IN with 105 CFU S. pneumoniae strain 
D39 in 10 l (supplied by Peter Andrew, University of Leicester, UK) (Haste et al., 2014).  
One day post-inoculation, the ME infection rate (63%) and titers (104.2 CFU/l, 103.4 – 104.9 
95% CI, n=15) were similar to those seen following NTHi challenge. However on day 2, 
unlike with NTHi, there were unexpected deaths in 5 of 15 mice with this relatively low dose, 
and a small volume that would not be expected to infect the lower airway. The experiment 
was immediately terminated and retro-orbital blood samples from 3 of 10 survivors indicated 
bacteremia. In the surviving mice the ME infection rate was 50% and titers of 104.5 CFU/l 
(102.8 – 106.2 95% CI, n=10) were attained. Thus, the Jbo/+ infection model can support ME 
pathogens other than NTHi but for the pneumococcus this needs to be further explored using 
appropriately attenuated strains with reduced virulence. 
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 DISCUSSION 
A recent review of the use of animals in OM research concluded there is a need to improve 
our current animal models, develop new ones and use a diversity of species to ensure that 
differences between any one species and humans do not bias our data (Li et al., 2013). In this 
work we show that Junbo, a mutant mouse line that develops OM spontaneously, has 
significant potential for ME infection studies as it can be reproducibly infected with a single 
IN inoculum of NTHi. NTHi rapidly ascends the ET and colonizes the ME. NTHi infection is 
detected in bulla fluids at 1 hr, titers peaked between day 7-14 and 20% of individual ME 
were infected up to day 56. Mouse ME bacterial titers (104-105 CFU/l) are comparable to 
those reported in direct inoculation of the chinchilla ME (106 -107 CFU/ml) albeit that the 
volume of material recovered from the mouse is substantially less. Infection in the chinchilla 
was cleared by day 35 using the same NTHi strain set utilised in our study (Bouchet et al., 
2003).  
The Junbo infection model provides a number of new perspectives on OM 
pathogenesis. In keeping with other animal models, the ME of wild-type mice are not 
efficiently infected by NTHi following IN inoculation. Microspheres that are similar in size 
to NTHi are readily translocated into the ET in both wild-type and Junbo mice and by this 
measure there is no obvious deficit in ET barrier function in Junbo mice. Other studies have 
shown that co-infection with viruses such as adenovirus promotes NTHi infection in the 
chinchilla ME (Bakaletz, 2009) and influenza virus promotes pneumococcus ET ascension 
(McCullers et al., 2007) and ME infection (Short et al., 2013). Taken together, these findings 
suggest that coincident inflammation is a pre-disposing factor promoting successful ME 
bacterial colonization and infection via direct epithelial injury and/or increased mucosal 
barrier permeability leading to ME fluid accumulation and creation of a new niche for 
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 colonizing bacteria.  The hypoxic inflamed ME in Junbo mice (Cheeseman et al., 2011) may 
favor the growth of microaerophilic bacteria such as NTHi. 
The strong association between the incidence of ME and NP infection, the high 
number of NTHi in the ME relative to NP and exudate along the length of the ET suggests 
the ME can act as a reservoir for NP re-infection. The implication is that the ME 
compartment is not an evolutionary dead end for NTHi. The ME niche will impose strong 
selection pressure through altered nutrient, oxygen and host defense parameters compared to 
the NP environment, factors consistent with the evolution of a repertoire of adaptive gene 
expression, for example the phase variation characteristic of NTHi strains.  
The generation of GF Junbo mice revealed that bacteria are not necessary for OM to 
develop but accelerate its onset. The presence of foreign bodies in histological sections of 
bulla fluids shows that fine particulate matter can gain access to the ME via the ET. This 
suggests physical irritants, which may include exposure to ammonia in laboratory mice, can 
act as inflammatory stimuli. The importance of non-microbial inflammatory stimuli in OM is 
not surprising given the established role of cigarette smoke as a risk factor in OM (Cayé-
Thomasen et al., 2013). 
Perturbation of innate immunity in the Junbo mouse via impaired Evi1 negative 
regulation of NFkB (Xu et al., 2011) is likely to contribute to the inflammatory OM 
phenotype and susceptibility to NTHi infection. In this regard Junbo has similarities to other 
mouse mutants with innate immunity deficits (Leichtle et al., 2011) where inflammation and 
bacterial clearance following intra-bulla challenge is prolonged compared to immune 
competent inbred strains such as C57BL/6 (Ryan et al., 2006).  
The global activation of an innate immune response following introduction of NTHi 
directly into the naïve mouse ME bulla has been characterized in a recent infection study. 
Bulla inflammatory cells and mucosal hyperplasia and inflammation peaked at 2 days and 
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 returned to baseline by 7 days. Mucosal gene expression showed a temporal pattern of gene 
clusters associated with neutrophil and macrophage recruitment and activation leading to 
resolution. It was suggested that dysregulation of pro- and anti-inflammatory signalling may 
be an important feature of chronic or recurrent OM (Hernandez et al, 2015). 
NTHi express a number of ligands that may be recognized by different TLRs. In the 
context of experimental OM in the mouse, membrane associated NTHi ligands such as 
peptidoglycan and peptidoglycan associated proteins (e.g. P6) are TLR2 ligands and 
lipopolysaccharide activates TLR2 and TLR4 signalling (Leichtle et al., 2009). Destruction 
of NTHi in the OM lesion is likely to release bacterial DNA and CpG motifs that are ligands 
for TLR9 (Leichtle et al., 2012) and bacterial RNAs (see below) are ligands for TLR7 and 
TLR8. In children with AOM, TLR2 and TLR4 are significantly upregulated in bacterial 
culture positive bulla fluids compared to culture negative bulla fluids (Kaur et al., 2015). 
These TLRs signal through MyD88 to upregulate pro-inflammatory cytokines.  
In the Junbo mouse, antigen-presenting cells capable of recognizing bacterial ligands 
for TLRs are present in the bulla fluids at the initiation of infection, and the bulla fluids were 
culture positive for NTHi throughout the 14-day time course of the experiment. We cannot 
exclude the possibility that TLR ligands from endemic bacteria contribute to expression of 
response cytokines, but we were able to exclude this variable from the baseline control by 
using bulla fluids from sterile inflammation in GF Junbo mice. In NTHi challenged Junbo 
mice there is upregulation of TNFa, IL1-b, IL12a, Ccl5, and IL6 which are implicated as 
inflammatory mediators in OM (Juhn et al., 2008). Furthermore, TNFa, IL1-b, IL6, Ccl3, and 
Ccl4 are differentially expressed in culture positive compared with culture negative middle 
ear fluids from children with AOM (Kaur et al., 2015). IL17a is important in neutrophil 
inflammation in NTHi exacerbation of COPD (Roos et al., 2015). Expression of IL6 and Ccl5 
declined after initial NTHi infection whilst other cytokines showed sustained upregulation. 
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 Vegfa is a marker of chronic inflammatory hypoxia in Junbo OM (Cheeseman et al., 2011) 
but Vegfa expression was unaltered by NTHi infection. These results indicate that NTHi 
infection stimulates a host innate immune response and further elevates cytokine gene 
expression, but that NTHi infection itself does not exacerbate hypoxia and HIF signalling. 
By 7 days post-inoculation, NTHi infection is well established in the Junbo mouse 
ME and histology reveals an abscess-like structure with a core of necrotic neutrophils 
surrounded by viable and apoptotic neutrophils and foamy macrophages. The exudate 
neutrophil density is ~ 7 x 106 /l (Cheeseman et al., 2011) and 1-2 logs higher than viable 
NTHi (104-105 CFU/l). We interpret the punctate and aggregate NTHi hybridization signals 
as intact single or clustered bacteria, or RNA released from lysed bacteria. Pus consists of 
neutrophils surrounded by neutrophil extracellular nets formed when the cell and nuclear 
membranes breakdown and release chromatin (Brinkmann and Zychlinsky, 2012). The 
extracellular histones formed in this process can have powerful antimicrobial effects and 
stimulate sterile inflammation via activation of the NLRP3 inflammasome (Allam et al., 
2014). The impact of the host innate immune response on NTHi population dynamics will be 
a key determinant of changes in host-microbe interaction and disease and requires further 
investigation. Also, there are major implications concerning the extreme bottleneck occurring 
in the pathogenesis of OM, indicated by the monoclonal cultures (strain 375 or 162lux but 
not both) of ME exudate. Once initiated, ME infection rates remain high up to 14 days post-
inoculation; it is not known whether NTHi titers were held in check by the immune response 
and/or other mechanisms such as host sequestration of nutrients, for example iron (Szelestey 
et al., 2013), contribute to limiting NTHi population growth. Unlike the infected ME of the 
chinchilla where NTHi is known to form a biofilm, our immunohistochemical and in situ 
hybridization analyses provided no clear evidence consistent with this mode of bacterial 
growth in the Junbo mouse ME bulla. It is likely that the inflamed hypoxic environment and 
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 the high incidence of other microbial flora that can exist in the Junbo mouse ME present a 
substantially different growth challenge for NTHi than that provided when infecting the 
sterile chinchilla ME (Jurcisek and Bakaletz, 2007, Brockson et al., 2014). The maintenance 
of NTHi infection in the mouse for periods of at least 8 weeks provides an opportunity to 
carry out longitudinal infection studies whereby the host response and concomitant microbial 
within host adaptation and population dynamics can be studied and compared over time 
within and between individual mice.  
Having established the basic dynamics of NTHi infection in the Junbo mouse we 
carried out two translational studies using quantitative end points. We have shown significant 
protection of the Junbo mouse following immunization with killed NTHi bacteria then IN 
challenge with the homologous NTHi strain. Junbo mice immunized with heterologous NTHi 
strains then infected with NTHi 162sr failed to show protection as indicated by infection rate, 
but some reduction in ME titer was observed. This likely reflects the substantial genetic and 
phenotypic heterogeneity that exists within natural populations of NTHi and the implicit 
challenge in developing a vaccine against NTHi OM and other diseases. These data offer 
proof in principle that the Junbo infection model could be used for relatively high throughput 
screening of candidate NTHi vaccine antigens. In clinical practice, antibiotic resistance is on 
the increase for NTHi and will potentially have a major impact on OM treatment regimens. 
The Junbo mouse model has demonstrated potential utility for investigating improved 
antibiotic treatments. A 3-day treatment of NTHi infected mice with systemic Azithromycin 
cleared ME infection, opening the possibility for the model to be used to either screen novel 
antibiotics for treatment, or design improved regimens and routes of delivery. An important 
feature of the Junbo OM model for future studies is the inflammatory thickening of the TM 
(Parkinson et al., 2006) as seen in human patients (Berger et al., 1996), making it a suitable 
model for testing trans-TM delivery of antibiotics.  
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 In summary, mouse models offer the general advantages of relatively low costs, better 
availability of immunological reagents, and ease of control of host genetics and microbial 
status. In this study we tested 3 mouse lines Junbo, Tgif and Jeff, each with a characterised 
mutation mediating a differing susceptibility to NTHi infection. Several genes associated 
with increased susceptibility to spontaneous OM in the mouse have now been shown to be 
relevant to human disease through candidate gene studies in family-based cohorts (Rye et al., 
2010). As new candidate human OM disease genes are discovered, their role in NTHi 
susceptibility could be investigated through the use of genetically modified mouse models. 
The high efficiency and reproducibility of IN inoculation in the Junbo mouse provides a 
robust platform to investigate aspects of host-microbial interaction, and the innate immune 
response to NTHi, and to test an adaptive immune response and antibiotic treatment against 
NTHi which have wide translational potential for clinical intervention. Lastly the Junbo 
model uses a non-invasive IN challenge route and a single terminal assessment, rather than 
re-sampling the same animal, and therefore represents welfare refinement.  
MATERIALS AND METHODS 
Ethics statement  
Full details of these studies were reviewed and approved by MRC Harwell ethical review 
committee. The humane care and use of mice in this study was carried out under the authority 
of the appropriate UK Home Office Project License.  
Mouse strains  
The majority of experiments used Junbo mice that were congenic on a C3H/HeH genetic 
background (Parkinson et al., 2006) and this mouse strain is available from the European 
Mouse Mutant Archive (EM:00091). For non-academic groups the Junbo model is available 
through MRC Technology.  
http://www.licensingopportunities.co.uk/research-tools/79/otitis-media/ 
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 For comparative purposes Junbo mice congenic on a BALB/c background were used 
in other infection studies. Tgif mice were congenic on a C57BL/6J background (Tateossian et 
al., 2013) and Jeff mice (EM:00375) (Hardisty-Hughes et al., 2006) were on a mixed 
C3H/HeH and C57BL/6J genetic background.  
Husbandry and microbiological surveillance of SPF Junbo, Tgif and Jeff mice  
SPF mice were housed in individually ventilated cages (Tecniplast) under a 12-hr light/12-hr 
dark cycle, temperature of 21 ± 2oC and humidity of 55 ± 10% on autoclaved Datesand grade 
6 pine bedding. Mice were fed an irradiated expanded RM3 diet (Special Diets Services, 
Witham, UK), and given water ad libitum. Air changes were 70-75 per hr. Microbiological 
surveillance of sentinel mice from our SPF animal facility was performed by Harlan 
laboratories following the FELASA screening guidelines. 
SPF mice that were challenged with bacteria were housed in a Biological 
Containment Unit IVC rack (Allentown) operated at negative pressure with an exhaust rate of 
35.7 m3 per hr.  
Generation and microbiological surveillance of germ free (GF) Junbo mice 
Germ Free C3H/HeJ stock was obtained from the CDTA-CNRS (Orleans, France). GF Junbo 
and C3H/HeH mice were re-derived by hysterectomy on day E19.5 of pregnancy to establish 
a breeding colony. GF mice were reared on irradiated Alpha-Dri substrate (SPP), plus 
shredded paper bedding and were housed in wire-topped cages within sterile flexible film 
isolators (Harlan-Isotec) fitted with DPTE alpha ports (La Calhene) . GF mice were provided 
irradiated RM3 diet and autoclaved water ad libitum.  
The isolators were maintained under positive pressure (5 to 10 mm water) operated at 
12-15 air changes per hr. Feces, urine and bedding were tested every 4 weeks for the 
presence of fungi, anaerobic and aerobic bacteria using Sabourauds media (Becton 
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 Dickinson), Thioglycolate media (Becton Dickinson) and nutrient broth (Becton Dickinson), 
respectively.   
Histology, immunohistochemistry and in situ hybridization 
Middle ear histology in GF and SPF mice was assessed in Haematoxylin and Eosin stained 
sections of 3 m wax sections as previously described (Cheeseman et al., 2011).  
To examine the histology of NTHi infected bullae by immunohistochemistry (n=6) or by in 
situ hybridization and lesion profiling, 11–week-old Jbo/+ mice (n=6) were inoculated IN 
with 106 CFU NTHi 162 and heads collected 7 days post-inoculation were fixed 48 hours in 
neutral buffered formalin. Non-challenged Jbo/+ mice (n=5) collected at the same time 
served as negative controls. For immunohistochemistry EDTA decalcification was 5-7 days. 
To maximize RNA integrity for in situ work, a band saw was used to isolate the bullae from 
fixed heads and EDTA decalcification achieved in 48 hours. 
For immunohistochemistry 4 m thick wax sections were cut onto electrostatically 
charged slides and dried overnight at 37oC before a final drying at 60oC for 25 minutes.  
Sections were de-waxed in xylene, hydrated through ethanol and washed three times in Tris 
Buffer.  Endogenous peroxidase was blocked using Dako REAL peroxidase blocker (S2023) 
for 10 minutes following antibody incubations.  
Rat monoclonal anti F4/80 (Serotec MCA497G) was used to detect macrophages. 
Antigen retrieval was performed using Dako proteinase K (S3020) for 20 minutes at room 
temperature. The antibody was diluted 1/400 and incubated for 30 minutes at room 
temperature. Secondary detection was carried out using the Vector Labs ImmPress HRP anti 
rat kit (MP-744-15) as per the manufacturer’s instructions.  Rabbit polyclonal anti cleaved 
Caspase 3 (Abcam ab2302) was used to detect apoptotic cells, and Rabbit polyclonal anti 
Histone 3 (Abcam ab61251) to detect histones. Antigen retrieval was carried out using 
Vector High pH antigen retrieval reagent at 60oC for 12 hrs. The rabbit polyclonal antibodies 
D
is
ea
se
 M
o
de
ls
 &
 M
ec
ha
ni
sm
s 
• 
D
M
M
 •
 A
dv
an
ce
 a
rt
ic
le
 were diluted 1/20 or 1/50 for Caspase 3 and Histone 3 respectively and incubated for 60 
minutes at room temperature. Secondary detection was carried out using Dako (K4011) 
Envision+ System HRP anti Rabbit as per the manufacturer’s instructions. Antibodies were 
diluted in Dako antibody diluent (S0809) and negative controls were carried out using the 
antibody diluent alone. Visualisation was achieved using Dako (K3468) liquid DAB+ 
substrate chromogen system. Counterstaining was carried out using Harris haematoxylin 
prior to dehydration through ethanol, clearing in xylene and mounting in Clearview mountant 
(Thermo Fisher Scientific). 
For lesion profiling, bright field images of Haematoxylin and Eosin stained sections 
were acquired using a Hamamatsu NanoZoomer slide scanner and the morphometric 
measurements were made using NanoZoomer software. The average thickness of the mucosa 
lining the medial surface of the bulla (avoiding the cochlea and the region close to the 
Eustachian tube) was calculated by dividing the area of mucosa overlying delineated ~1000 
µm length of supporting bulla bone.  The proportion of bulla space occupied by exudate was 
calculated by dividing the exudate area by the area bounded by bulla mucosa surface and the 
tympanic membrane. The treatment groups were blinded for the slide analysis.  
In situ hybridization was performed on 4 m wax sections of representative NTHi 
challenged (n=2) and non-challenged (n=2) Jbo/+ mice heads using probe B-HInfluenzae-
NTHi375-16SrRNA as per the manufacturer’s instructions (Advanced Cell Diagnostic) using 
the HRP visualisation kit. A positive control for RNA integrity (PpiB) and a negative 
hybridization control (DapB) (Advanced Cell Diagnostic) were used.  
Intranasal administration of FITC microspheres  
Nine week old Jbo/+ (n=6) and wild-type littermate (n=9) mice were anaesthetized 
with isofluorane and ~108 FITC-microsphere beads (1.0 m blue-green fluorescent (430/465) 
polystyrene microspheres, Life Technologies) administered IN by applying 5 l of 
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 suspension to each nostril.  The mice were euthanized at ~5 minutes using a rising 
concentration of CO2 and the heads fixed in neutral buffered formalin. EDTA decalcified 
heads were prepared for cryostat sectioning of the ET. Ten m coronal serial sections of the 
ET were mounted on consecutive slides. A representative slide with range of ET levels was 
counterstained with DAPI and mounted in Prolong antifade reagent (Molecular Probes). The 
sections were scanned and the number of FITC microspheres were counted in representative 
levels of each ET and expressed per mm of ET profile. The mouse genotypes were blinded 
for the slide analysis. 
Bacterial strains for inoculum preparation and immunization  
NTHi strains used in the study are well characterised, phylogenetically distinct strains (162, 
176, 285, 375, 486, 1124, 1158) from human OM (Cody et al., 2003), and 2019. Growth of 
indigenous commensal bacterial flora, particularly of Proteus spp., rendered a proportion of 
bacterial count plates unreadable. For this reason, NTHi strains expressing resistance to 
streptomycin or kanamycin (eg NTHi 162sr or 162kr) were generated.  Spontaneous 
streptomycin resistant colonies were selected after plating bacteria at high density (2 x 1010 
CFU/plate) on streptomycin (300 g/ml) containing media. Strain 162kr was made through 
insertion of a kanamycin resistance cassette onto a position in the NTHi genome (HI0227) 
that had no characterized phenotype. These strains enabled antibiotic selection of NTHi 
during culture and counter-selection against any indigenous bacteria; this increased the 
number of ME providing quantitative data during experiments.  
Strain NTHi 162lux was constructed by transforming strain 162 with the luxCDABE 
genes using chromosomal DNA isolated from H. influenzae strain Xen21 (Caliper Life 
Sciences). 
Bacteria from -80oC stocks were grown overnight at 37oC in 5% CO2 atmosphere on 
Brain Heart Infusion-Levinthals (BHI-Lev) agar then used to inoculate BHI-Lev broth and 
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 grown to log-phase prior to preparing the animal inoculum. Inoculum size was calculated 
from optical density measurement using the conversion factor that an OD A490 of 0.4 = 1x10
9 
CFU/ml. Bacteria were pelleted by centrifugation at 13000xg for 3 minutes then re-
suspended to 1010 CFU/ml in PBS/2% gelatin. The titer of each inoculum was assessed pre- 
and post-inoculation by dilution and plating.  
For subcutaneous immunization of mice, bacteria from liquid culture were pelleted, 
resuspended in PBS then killed by treatment with 1% paraformaldehyde (PFA) (1hr at 37oC, 
then overnight at 4oC); loss of viability was confirmed by plating. Killed NTHi were stored in 
1% PFA for up to 5 weeks at 4oC and their integrity assessed by phase contrast microscopy. 
Before use, the bacteria were pelleted by centrifugation at 13000xg for 3 minutes and re-
suspended to give 1010 CFU/ml in PBS then mixed with Adjuplex (Sigma) adjuvant 
according to the manufacturer’s instructions. 
Intranasal challenge 
SPF mice aged either 8 ± 1 week or 12 ± 1 week were anesthetized with isofluorane and 5 l 
of the 10 l inoculum applied to each nostril. For each time point in an experiment, mice in 
cohorts of 11-15 animals were inoculated with doses ranging from 103 -108 CFU.  
Terminal sampling of blood, bulla fluids and nasopharynx 
Bulla fluids were sampled terminally via the TM as previously described (Cheeseman et al., 
2011) and the volume estimated using 0-2 l filtered pipette tip (average volume 0.5 l, 
range 0.1-1.25 l) then transferred into 500 l of PBS. In  wild-type mice and in a proportion 
of Jbo/+ ME, the TM was clear and there was no detectable bulla fluid. These bullae were 
washed twice with 2 l of sterile PBS and the washings added back to 500 l of PBS.  
In some experiments the NP was sampled after collecting bulla fluids by washing 
with 200 l PBS introduced into the NP opening on the palate and collecting the wash fluid 
from the nares. To ensure this order of collection did not displace ME NTHi and bias NP 
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 numbers recovered, the NP was sampled first in one cohort of n=15 mice; the infection rate 
was found to be not significantly different (67% versus 80% P=0.6816, Fisher exact test 
n=15 mice per group) and the titers comparable when the NP is sampled either before or after 
the ME (101.1 and 101.6 respectively).   
NTHi culture of ME bulla fluids and NP wash.  
Bulla fluids and NP washes in PBS were mixed by three 10 sec bursts on a vortex mixer then 
10-fold dilutions (10-1, 10-2) were made in PBS. 50 l of each ME dilution or NP wash was 
spread on a BHI-Lev agar plate. The detection limit was 10 CFU/l for the primary bulla 
fluid preparation and 100 CFU/l for the 10-1 dilution. The primary bulla fluid suspension 
was centrifuged at 13000xg for 3 minutes and the pellet frozen on dry ice then stored at -
80OC for RNA isolation (see below).  
In experiments using antibiotic resistant strains, bulla samples were plated on media 
supplemented with 300 g/ml streptomycin or 30 g/ml kanamycin. The ME commensal 
bacteria were assessed using a non-selective plate in parallel. Plates were cultured overnight 
at 37OC to calculate NTHi titers. Representative NTHi colonies were examined by phase 
contrast microscopy to confirm its small coccobacillus morphology.  
In the co-infection experiment with NTHi 162lux and 375 (5 x 105 CFU each strain 
IN), a monoculture is defined as ≥10 colonies all of the same strain (either 162lux or 375) on 
the BHI primary culture plate.  
Infection rates and bulla fluid titer 
To compare ME infection rates we used an index of infected bulla fluids: 
                  NTHi positive bulla cultures  
NTHi positive cultures + NTHi negative cultures 
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 Two categories were excluded from this index: PBS bulla washes (because they yielded a 
very low percentage with NTHi growth) and, in experiments using non-antibiotic resistant 
NTHi strains, bulla fluids that gave Proteus overgrowth preventing NTHi detection. The ME 
NTHi titer (CFU/l) was calculated from plate counts, sample dilution and bulla fluid 
volume. 
Bioluminescent imaging  
Mice were inoculated with NTHi 162lux and bioluminescent signals from the head (oral 
cavity aspect of the palate after dissecting away the mandible) or, for dual infection studies, 
the proportion of NTHi colonies on the BHI ME culture plates were imaged using an IVIS 
Lumina II system (Perkin Elmer).  
Real time quantitative PCR (RT-qPCR) of bulla fluids  
8 week old SPF Jbo/+ mice were inoculated with 106 CFU NTHi 375 and cohorts were 
sampled terminally at days 1, 3, 7, 10 and 14 post-inoculation. Cell pellets (n=4-6) were 
pooled from bulla fluids that yielded NTHi monocultures on the 10-1 dilution plate 
(equivalent to <100 CFU/l commensal bacterial) and for each time point there were n=3-6 
biological replicate pools. Bulla fluids from 8-10 week old GF Jbo/+ mice were collected 
into 20 l of RNase free water for RNA isolation and used as a baseline expression control. 
Each GF pool comprised n=4-6 bulla fluids and there were n=10 biological replicates. RNA 
extraction, cDNA synthesis and RT-qPCR TaqMan were performed as previously described 
(Cheeseman et al., 2011) for Ccl3, Ccl4, Ccl5, IL-1b, IL-6, IL-12a, IL-17a, Tnfa and Vegfa. 
RT-qPCR was performed in triplicate technical assays. Data was normalized using Hrpt1 and 
beta Actin as the endogenous control and fold changes of expression (ddCts) of NTHi 
infected bulla fluid white blood cells over non-infected white blood cells were calculated 
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 using AB 7500 software v2.0.1 and expressed as mean relative quantification (RQ) ± 
min/max error bars representing 95% CI. 
Immunization with NTHi bacteria 
Each Jbo/+ mouse received 3 subcutaneous immunizations in intra-scapular skin with 108 
CFU killed bacteria and adjuvant in 50 l. Immunizations were at the age of 5, 8 and 10 
week. Mice were immunized with either NTHi 162sr, 176 or 375 then inoculated IN at 12 
weeks with 106 CFU NTHi 162sr. ME infection was assessed at 7 days post-inoculation. 
Azithromycin treatment of NTHi infection 
8-week-old Jbo/+ mice were treated using a 3-day course of 100 mg/kg Azithromycin 
delivered once a day by oral gavage. Treatment started at day 4 post IN-inoculation with 106 
CFU NTHi 162 and bulla fluids sampled on day 7. A sham-treated control group was 
gavaged with vehicle alone (2% methoxycellulose solution). The MIC for NTHi 162 was 
determined to be 1g/ml. 
Statistical analysis  
Log10 normalized NTHi titers were analyzed using t-tests (mouse strain susceptibility data, 
immunization data and antimicrobial data) or by one-way ANOVAs and Tukeys multiple 
comparison tests for post-hoc testing (inoculation dose data and 24 hr time course data). ME 
mucosa thickness, bulla fluid area proportions and microsphere counts per mm of ET were 
analyzed with a Mann-Whitney test. Fisher exact and Chi-squared tests were used to analyze 
frequency data (TM phenotypes, occurrence of bulla fluids, ME and NP infection rates). Data 
are presented as mean ± SE, mean ± 95% CI, or median ± 95% CI. 2-tailed test values 
P<0.05 were considered significant. 
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 Figures 
 
 
 
Fig. 1. IN-inoculation with different NTHi strains produces variation in ME infection 
rate and bacterial titer, but for NTHi 162 these parameters do not vary over a 104 to 108 
CFU inoculum dose. Jbo/+ mice were sampled 7 days post IN-inoculation with different 
NTHi strains (A) ME infection rates and (C) titers vary with NTHi strain. For NTHi 162 (B) 
ME infection rate and (D) titers were not significantly different when inoculum doses were 
used over the range of 104 -108 CFU; n=11-12 mice per cohort, data are represented as mean 
± 95% CI.  (B) Fisher exact test, (D) 1-way ANOVA; NS not significant.  
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Fig. 2.  Time course of NTHi ME infection. (A) A bioluminescent signal from 108 CFU 
NTHi 162lux is evident level with opening of the NP (arrow) minutes after IN inoculation of 
three Jbo/+ mice. A 24 hr time course for (B) ME infection rate and (D) log10 titers in 12 
week Jbo/+ mice inoculated with 106 CFU NTHi 162sr (detection limit of 10 CFU/l); 
extended time course from 1-56 days post-inoculation (detection limit of 100 CFU/l) (C) 
ME infection rate and (E) log10 titers; n=13-15 mice per time point, data are represented as 
mean ± 95% CI. (D) 1-way ANOVA P<0.001; using Tukeys multiple comparison tests, the 
NTHi titers at 1 hr, 3 hr and 6 hr are not significantly different from one another, however 
each is significantly different from the NTHi titer at 24 hr (**P<0.01). 
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Fig. 3.  Histopathology of the Jbo/+ mouse ME 7 days post inoculation with NTHi. 
Composite histological features from three 12 week Jbo/+ mice 7 days post IN-inoculation 
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 with 106 CFU NTHi 162. (A) and (B) a higher magnification inset of a Haematoxylin and 
Eosin stained section of ME bulla, tympanic membrane (tm) arrow. Bulla fluid has a caseous 
core of necrotic neutrophil leukocytes (c) surrounded by viable neutrophil leukocytes (nl) and 
foamy macrophages (fm); inflamed ME mucosa (m) and bulla bone (b). (C) F 4/80 antibody 
positive foamy macrophages in bulla fluid (fm) and macrophages in the inflamed mucosa 
(arrows). (D) and (E) a higher magnification inset of cleaved caspase 3 positive apoptotic 
cells (arrows). (F) Two of six bulla fluids had large extracellular accumulations of 
Haematoxylin positive chromatin (arrows). (G) The larger chromatin foci were histone 3 
antibody negative (white arrows) but finely granular extracellular histone 3 positive material 
(black arrow) was scattered in the caseous core. Note normal histone staining of neutrophil 
and epithelial nuclei. (H) Neutrophils in Eustachian tube (et) lumen adjacent to the bulla 
opening and (I) at the nasopharynx junction (np) (black arrows), neutrophil leukocyte 
infiltration in ET submucosa (white arrows).  (J, K) Jbo/+ mouse inoculated with NTHi 
162sr and probed with B-HInfluenzae-NTHi375-16SrRNA oligonucleotide (Advanced Cell 
Diagnostic) and visualized using HRP and DAB. Bulla fluid exudates have chromogen 
deposits (arrows) that appeared as scattered punctate signals (~ 1 μm) or irregular aggregates 
(10-20 μm greatest dimension), the mucosa margin is marked (m). NTHi hybridisation 
signals were absent in non-inoculated Jbo/+ control mice (L, M). A positive control probe 
(Ppib) for mouse RNA integrity showed punctate signals in mucosal epithelium and bulla 
fluid cells but no signal was obtained with a negative control probe (bacterial DapB gene) 
data not shown.   
Scale bars A = 500 m, B,H = 200 m, C,D,F = 100 m, E,G,I = 50 m. Asterix (*) marks 
an artefactual cleft caused by histology processing in panels A,C,F.  J and L magnification 
x200 scale bar = 200 m, K and M x1000 oil immersion scale bar = 20 m. 
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Fig. 4.  Jbo/+ mice develop otitis media in germ free (GF) conditions. (A) Time course of 
the proportion of Jbo/+ GF mice with unilateral or bilateral otitis media (the number of mice 
is indicated alongside each time point). Histological analysis of Jbo/+ mouse ME (B-F). (B) 
Haematoxylin and Eosin stained sections of non-inflamed ME of a 4 week GF Jbo/+ mouse 
with an air filled bulla space, thin mucosa (m) indicated between arrows, supported by 
underlying bulla bone (b); (C) inflamed ME of a 4 week SPF Jbo/+ mouse with exudate (e) 
in the bulla space, and thickened mucosa (m); (D-E) inflamed ME of GF Jbo/+ with bulla 
exudate (e) and thickened mucosa (m) at (D) 5 weeks of age ; and (E) 8 weeks of age; (F) 
ME exudate in a 12 week GF Jbo/+ mouse contains plant-based foreign body (fb) in bulla 
exudate (PAS stained section). Scale bars B-F= 50 m. 
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Fig. 5. NTHi monocultures predominate 7 days after co-inoculation with two strains. 
Jbo/+ mice were co-inoculated with 5 x 105 CFU each of NTHi 162lux and NTHi 375. (A) 
dual infections predominate on day 1 post infection, but single infections predominate on day 
7; (B) the ME infection rate remains high from day 1-7; (C) ME titers are comparable for 
162lux and 375 in co-infections. Data are represented as mean ± 95% CI and overlapping 
error bars are omitted; (D) the proportion of single infections with NTHi 162lux predominate 
at day 7. The number of monocultures is indicated alongside each time point. 
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Fig. 6.  Host innate immune response in NTHi infected bulla fluids.  ME infection rate 
(A) and titer (B) in 8 week Jbo/+ mice inoculated with 106 CFU NTHi 375 (n=12 per cohort) 
mean ± 95% CI. (C-E) modulation of gene expression in NTHi infected ME samples relative 
to GF ME samples detected by RT-qPCR. Each time point represents biological replicate 
pools of n=3-6 NTHi infected ears and n=10 biological replicate pools of GF bulla samples 
as baseline controls; data are represented as mean relative quantification (RQ) ± 95% CI.  
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Fig.7. Homologous and heterologous protection for mice immunized with killed NTHi 
bacteria.  (A) Jbo/+ mice immunized 3 times subcutaneously with 108 killed NTHi 162 (but 
not 176 or 375) had a significantly lower ME infection rate when inoculated with 106 CFU 
NTHi 162sr compared to PBS immunized controls (B) Jbo/+ mice immunized with either 
killed NTHi 162, 176 or 375 had significantly lower ME titers than PBS controls. n=14-15 
mice per cohort for NTHi 176 and 375 immunized mice and n=30 for NTHi 162 and PBS; 
data are represented as mean ± 95% CI. (A) Fisher exact tests comparing infection rates for 
each NTHi strain with the PBS control, (B) t-tests comparing titers for each NTHi strain with 
the PBS control; NS not significant, **P<0.01, ***P<0.001. 
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Fig. 8. Azithromycin treatment eliminates NTHi infection. Time course of (A) ME 
infection rate and (C) titer for 8 week Jbo/+ mice inoculated with 106 CFU NTHi 162 (n=11-
12 per time point). (B,D) Jbo/+ mice were treated with 100 mg/kg Azithromycin (AZM) by 
oral gavage once a day for 3 days starting on day 4 post-inoculation with 106 CFU NTHi 162, 
and sampled at day 7. (B) ME infection rate was significantly reduced in the AZM treatment 
group. (D) NTHi titer in the vehicle treated group was 105.3 CFU/l (10 5.1-10 5.4) whereas 
NTHi were not detected in the AZM treated group (detection limit 102 CFU/l), n=15 Jbo/+ 
per group. Data are represented as mean ± 95% CI. (A) Fisher exact test, (B) 1-sample t-test 
using a hypothetical sample mean of 102 CFU/l; ***P<0.001 
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TRANSLATIONAL IMPACT 
Clinical Issue  
Acute otitis media, inflammation of the middle ear, is the most common bacterial infection in 
children and reason for antimicrobial prescription to this age group. There is currently no 
effective vaccine for the principal pathogen, non-typeable Haemophilus influenzae (NTHi) 
and oral antibiotics have marginal clinical benefit. 
The chinchilla is the standard animal model for AOM vaccine research and uses direct 
injection of bacteria into the middle ear. The natural route of middle ear infection is by nasal 
bacteria ascending via the Eustachian tube. Middle ear infection via intranasal inoculation 
requires barotrauma to translocate bacteria or co-infection with viruses.  The mouse is an 
alternative model for NTHi infection studies. The role of innate immunity genes on 
susceptibility to otitis media has been intensively studied in genetically altered mice using the 
wide range of reagents available for protein and gene expression analyses in this species. 
Following intranasal challenge NTHi infection in wild-type mice resolves spontaneously 
within 7 days.  
Results   
We have modeled NTHi infection in specific pathogen free Junbo mice. The Junbo mouse 
bears a mutation in the Evi1 (Mecom) transcription factor, an inducible negative regulator of 
NFkB, the transcription factor that is the master regulator of inflammatory networks. The 
Junbo mouse spontaneously develops inflammatory disease that is restricted to the middle 
ear; this inflammation predisposes mice to middle ear infection after a single intranasal 
inoculation of NTHi. Middle ear infection rate and NTHi titers peak between 4-14 days post 
inoculation followed by clearance. 20% of middle ears remain infected after 56 days. The 
high infection rate and bacterial titer achieved in the bulla fluids makes the Junbo mouse a 
reproducible model to study interventions and we show protection by immunization with 
killed homologous NTHi strains and infection clearance using oral Azithromycin.  
Implications and future directions  
The Junbo infection model has utility for translational studies. Small cohorts of mice are 
sufficient to screen individual candidate antigens and/or immunization routes for vaccination.  
Inflammatory disease of the middle ear in humans and Junbo mice causes thickening of the 
tympanic membrane. The model is potentially useful to develop ototopical delivery systems 
to improve therapeutic response, reduce the use of oral antibiotics and thereby the risk of 
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 emerging antibiotic resistance. The Junbo model is available to researchers through the 
European Mouse Mutant Archive and MRC Technology. 
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